Alpha-glucosidase inhibitor
Alpha-glucosidase inhibitor
Alpha-glucosidase inhibitors (== Template:IPA ==
The Template:IPA (International Phonetic Alphabet) is a system of phonetic notation based primarily on the Latin alphabet. It was devised by the International Phonetic Association in the late 19th century as a standardized representation of the sounds of spoken language.
Pronunciation
The pronunciation of the term "IPA" is /aɪ piː eɪ/ in English.
Etymology
The term "IPA" is an acronym for the International Phonetic Alphabet. The International Phonetic Association, founded in 1886, created the IPA to provide a single, universal system for the transcription of spoken language.
Related Terms
- Phonetic notation: A system used to visually represent the sounds of speech. The IPA is one type of phonetic notation.
- Phonetics: The study of the physical sounds of human speech. It is concerned with the physical properties of speech sounds (phonemes), and the processes of their physiological production, auditory reception, and neurophysiological perception.
- Phonology: The study of the way sounds function within a particular language or languages. While phonetics concerns the physical production, acoustic transmission and perception of the sounds of speech, phonology describes the way sounds function within a particular language or languages.
- Transcription (linguistics): The systematic representation of spoken language in written form. The source of the words transcribe and transcription, the term means "to write across" in Latin, and it's the process of converting spoken language into written form. In linguistics, this is often done using the IPA.
External links
- Medical encyclopedia article on Alpha-glucosidase inhibitor
- Wikipedia's article - Alpha-glucosidase inhibitor
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski) are a class of antidiabetic drugs used for the management of Type 2 diabetes.
Etymology
The term "Alpha-glucosidase inhibitor" is derived from the enzyme Alpha-glucosidase which it inhibits. Alpha-glucosidase is an enzyme responsible for breaking down carbohydrates into simpler sugars. The term "inhibitor" refers to the drug's ability to inhibit or reduce the activity of this enzyme.
Mechanism of Action
Alpha-glucosidase inhibitors work by slowing down the digestion of carbohydrates in the small intestine, thereby delaying glucose absorption and reducing postprandial hyperglycemia (high blood sugar levels after meals). They achieve this by inhibiting the alpha-glucosidase enzyme found in the brush border of the small intestines.
Examples
Examples of alpha-glucosidase inhibitors include Acarbose, Miglitol, and Voglibose. These drugs are often used in combination with other antidiabetic drugs to achieve better glycemic control.
Side Effects
Common side effects of alpha-glucosidase inhibitors include gastrointestinal problems such as flatulence, diarrhea, and abdominal pain. These side effects are usually mild and decrease over time as the body adjusts to the medication.
Related Terms
External links
- Medical encyclopedia article on Alpha-glucosidase inhibitor
- Wikipedia's article - Alpha-glucosidase inhibitor
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski